UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
[X]
|
Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| For the period ended February 29, 2004. | ||
[ ]
|
Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| For the transition period from to . | ||
| Commission File Number 1-9927 |
COMPREHENSIVE CARE CORPORATION
| Delaware | 95-2594724 | |
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
200 South Hoover Blvd, Suite 200, Tampa, FL 33609
(813) 288-4808
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
Indicate the number of shares outstanding of each of the issuers classes of Common Stock, as of the latest practicable date: .
| Classes | Outstanding at April 8, 2004 | |
| Common Stock, par value $.01 per share | 4,673,049 |
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Index
| Page | ||||||||
| 3 | ||||||||
| 4 | ||||||||
| 5 | ||||||||
Notes to Consolidated Financial Statements |
6-10 | |||||||
| 11-17 | ||||||||
| 17 | ||||||||
| 17-18 | ||||||||
| 19 | ||||||||
| 19 | ||||||||
| 19 | ||||||||
| 20 | ||||||||
| 21-24 | ||||||||
| Ex-31.1: Section 302 Certification-CEO | ||||||||
| Ex-31.2: Section 302 Certification-CFO | ||||||||
| Ex-32.1: Section 906 Certification-CEO | ||||||||
| Ex-32.2: Section 906 Certification-CFO | ||||||||
2
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
PART I. FINANCIAL INFORMATION
Item 1 Consolidated Financial Statements
Consolidated Balance Sheets
| February 29, | May 31, | |||||||
| 2004 |
2003 |
|||||||
| (unaudited) | ||||||||
| (Amounts in thousands) | ||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 3,175 | $ | 3,590 | ||||
Accounts receivable, less allowance for doubtful accounts of $0 and $27 |
421 | 75 | ||||||
Accounts receivable managed care reinsurance contract |
420 | 354 | ||||||
Other current assets |
274 | 605 | ||||||
Total current assets |
4,290 | 4,624 | ||||||
Property and equipment, net |
356 | 230 | ||||||
Note receivable |
| 155 | ||||||
Goodwill, net |
991 | 991 | ||||||
Restricted cash |
327 | 328 | ||||||
Other assets |
46 | 51 | ||||||
Total assets |
$ | 6,010 | $ | 6,379 | ||||
LIABILITIES AND STOCKHOLDERS DEFICIT |
||||||||
Current liabilities: |
||||||||
Accounts payable and accrued liabilities |
$ | 1,560 | $ | 1,836 | ||||
Accrued claims payable |
3,608 | 4,103 | ||||||
Accrued reinsurance claims payable |
2,991 | 3,117 | ||||||
Income taxes payable |
22 | 15 | ||||||
Total current liabilities |
8,181 | 9,071 | ||||||
Long-term liabilities: |
||||||||
Long-term debt |
2,244 | 2,244 | ||||||
Other liabilities |
175 | 54 | ||||||
Total long-term liabilities |
2,419 | 2,298 | ||||||
Total liabilities |
10,600 | 11,369 | ||||||
Commitments and Contingencies (Note 5) |
||||||||
Stockholders deficit: |
||||||||
Preferred stock, $50.00 par value; authorized 18,740 shares; none issued |
| | ||||||
Common stock, $0.01 par value; authorized 12,500,000 shares; issued
and outstanding 4,663,049 and 3,936,549 |
47 | 39 | ||||||
Additional paid-in-capital |
52,945 | 51,928 | ||||||
Deferred compensation |
(5 | ) | (16 | ) | ||||
Accumulated deficit |
(57,577 | ) | (56,941 | ) | ||||
Total stockholders deficit |
(4,590 | ) | (4,990 | ) | ||||
Total liabilities and stockholders deficit |
$ | 6,010 | $ | 6,379 | ||||
See accompanying notes.
3
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
(Unaudited)
(Amounts in thousands, except per share amounts)
| Three months Ended | Nine months ended | |||||||||||||||
| February 29, | February 28, | February 29, | February 28, | |||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Operating revenues |
$ | 6,348 | $ | 8,061 | $ | 21,252 | $ | 24,999 | ||||||||
Costs and expenses: |
||||||||||||||||
Healthcare operating expenses |
5,520 | 7,227 | 18,571 | 22,340 | ||||||||||||
General and administrative expenses |
799 | 771 | 2,677 | 2,611 | ||||||||||||
Provision for (recovery of) doubtful accounts |
(2 | ) | 19 | (14 | ) | 5 | ||||||||||
Depreciation and amortization |
27 | 37 | 82 | 168 | ||||||||||||
| 6,344 | 8,054 | 21,316 | 25,124 | |||||||||||||
Operating income (loss) from continuing operations before
items shown below |
4 | 7 | (64 | ) | (125 | ) | ||||||||||
Other income (expense): |
||||||||||||||||
Net gain on IRS settlement |
| 7,717 | | 7,717 | ||||||||||||
Gain on settlement of other liability |
| | | 470 | ||||||||||||
Loss from prepayment of note receivable |
(20 | ) | | (20 | ) | | ||||||||||
Gain on sale of assets |
| | | 4 | ||||||||||||
Loss on disposal of assets |
| | | (5 | ) | |||||||||||
Interest income |
4 | 8 | 22 | 37 | ||||||||||||
Interest expense |
(57 | ) | (44 | ) | (159 | ) | (134 | ) | ||||||||
Other non-operating income |
| 25 | 1 | 33 | ||||||||||||
(Loss) income from continuing operations before income taxes |
(69 | ) | 7,713 | (220 | ) | 7,997 | ||||||||||
Income tax expense |
9 | 7 | 29 | 17 | ||||||||||||
(Loss) income from continuing operations |
$ | (78 | ) | $ | 7,706 | $ | (249 | ) | $ | 7,980 | ||||||
Loss from discontinued operations |
| | (387 | ) | | |||||||||||
Net (loss) income attributable to common stockholders |
$ | (78 | ) | $ | 7,706 | $ | (636 | ) | $ | 7,980 | ||||||
(Loss)
income per common share - basic: |
||||||||||||||||
(Loss) income from continuing operations |
$ | (0.02 | ) | $ | 1.97 | $ | (0.06 | ) | $ | 2.05 | ||||||
Loss from discontinued operations |
| | (0.09 | ) | | |||||||||||
Net (loss) income |
$ | (0.02 | ) | $ | 1.97 | $ | (0.15 | ) | $ | 2.05 | ||||||
(Loss) income per common share diluted: |
||||||||||||||||
(Loss) income from continuing operations |
$ | (0.02 | ) | $ | 1.71 | $ | (0.06 | ) | $ | 1.87 | ||||||
Loss from discontinued operations |
| | (0.09 | ) | | |||||||||||
Net (loss) income |
$ | (0.02 | ) | $ | 1.71 | $ | (0.15 | ) | $ | 1.87 | ||||||
Weighted average common shares outstanding: |
||||||||||||||||
Basic |
4,585 | 3,908 | 4,154 | 3,897 | ||||||||||||
Diluted |
4,585 | 4,509 | 4,154 | 4,277 | ||||||||||||
See accompanying notes.
4
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Unaudited)
| Nine months ended | ||||||||
| February 29, | February 28, | |||||||
| 2004 |
2003 |
|||||||
| (Amounts in thousands) | ||||||||
Cash flows from operating activities: |
||||||||
Net (loss) income from continuing operations |
$ | (249 | ) | $ | 7,980 | |||
Adjustments to reconcile net (loss) income from continuing operations
to net cash used in operating activities: |
||||||||
Depreciation and amortization |
82 | 168 | ||||||
Loss in connection with prepayment of note receivable |
20 | | ||||||
Provision for doubtful accounts |
| 5 | ||||||
Net gain on IRS settlement |
| (7,717 | ) | |||||
Gain on sale of assets |
| (4 | ) | |||||
Loss on disposal of assets |
| 5 | ||||||
Non-cash expense stock issued |
33 | 20 | ||||||
Compensation expense stock options and warrants issued |
29 | 9 | ||||||
Other non-operating gain |
| (470 | ) | |||||
Changes in assets and liabilities: |
||||||||
Accounts receivable |
(346 | ) | (259 | ) | ||||
Accounts
receivable - managed care reinsurance contract |
(66 | ) | 99 | |||||
Other receivable |
| 525 | ||||||
Other current assets, restricted funds, and other non-current assets |
240 | 409 | ||||||
Unbenefitted tax refunds received |
| (2,258 | ) | |||||
Accounts payable and accrued liabilities |
(420 | ) | (824 | ) | ||||
Accrued claims payable |
(495 | ) | (219 | ) | ||||
Accrued reinsurance claims payable |
(126 | ) | 883 | |||||
Income taxes payable |
7 | (1 | ) | |||||
Net cash used in continuing operations |
(1,291 | ) | (1,649 | ) | ||||
Net cash used in discontinued operations |
(53 | ) | | |||||
Net cash used in continuing and discontinued operations |
(1,344 | ) | (1,649 | ) | ||||
Cash flows from investing activities: |
||||||||
Net proceeds from sale of property and equipment |
| 3 | ||||||
Payments received on note receivable |
139 | 3 | ||||||
Additions to property and equipment |
(159 | ) | (37 | ) | ||||
Net cash used in investing activities |
(20 | ) | (31 | ) | ||||
Cash flows from financing activities: |
||||||||
Proceeds from the issuance of Common Stock |
974 | 14 | ||||||
Repayment of debt |
(25 | ) | (9 | ) | ||||
Net cash provided by financing activities |
949 | 5 | ||||||
Net decrease in cash and cash equivalents |
(415 | ) | (1,675 | ) | ||||
Cash and cash equivalents at beginning of year |
3,590 | 5,340 | ||||||
Cash and cash equivalents at end of period |
$ | 3,175 | $ | 3,665 | ||||
See accompanying notes
5
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 1 Summary of Significant Accounting Policies
The consolidated balance sheet as of February 29, 2004, and the related consolidated statements of operations for the three and nine months ended February 29, 2004 and February 28, 2003, and cash flows for the nine months ended February 29, 2004 and February 28, 2003 are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments necessary for a fair presentation of such financial statements have been included. Such adjustments consisted only of normal recurring items. The results of operations for the nine months ended February 29, 2004 are not necessarily indicative of the results to be expected during the balance of the fiscal year.
The consolidated financial statements do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. The balance sheet at May 31, 2003 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statement presentation. Notes to consolidated financial statements included in Form 10-K for the year ended May 31, 2003 are on file with the Securities and Exchange Commission and provide additional disclosures and a further description of accounting policies.
The Companys financial statements are presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recovery and classification of assets or the amount and classification of liabilities that may result from the outcome of the uncertainties described in Note 2 Basis of Presentation.
The Companys managed care activities are performed under the terms of agreements with health maintenance organizations (HMOs), preferred provider organizations (PPOs), and other health plans or payers to provide contracted behavioral healthcare services to subscribing participants. Revenue under a substantial portion of these agreements is earned monthly based on the number of qualified participants regardless of services actually provided (generally referred to as capitation arrangements). Such agreements accounted for 85.9%, or $18.2 million, of revenue for the nine months ended February 29, 2004 and 87.5%, or $22.0 million, of revenue for the nine months ended February 28, 2003. The balance of the Companys revenues is earned on a fee-for-service basis and is recognized as services are rendered.
Restricted Cash
As of February 29, 2004 and May 31, 2003, non-current restricted accounts include $0.3 million of cash held in trust in connection with the Companys Directors and Officers liability insurance policy.
Accrued Claims Payable
The accrued claims payable liability represents the estimated ultimate net amounts owed for all behavioral healthcare services provided through the respective balance sheet dates, including estimated amounts for claims incurred but not yet reported (IBNR) to the Company. The unpaid claims liability is estimated using an actuarial paid completion factor methodology and other statistical analyses and is continually reviewed and adjusted, if necessary, to reflect any change in the estimated liability. These estimates are subject to the effects of trends in utilization and other factors. However, actual claims incurred could differ from the estimated claims payable amount reported as of February 29, 2004. Although considerable variability is inherent in such estimates, management believes that the unpaid claims liability is adequate.
Income Taxes
The Company calculates deferred taxes and related income tax expense using the liability method. This method determines deferred taxes by applying the current tax rate to net operating loss carryforwards and to the cumulative temporary differences between the recorded carrying amounts and the corresponding tax basis of assets and liabilities. A valuation allowance is established for deferred tax assets unless their realization is considered more
6
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
likely than not. The Companys provision for income taxes is the sum of the change in the balance of deferred taxes between the beginning and the end of the period and income taxes currently payable or receivable.
Stock Options
The Company issues stock options to its employees and non-employee directors (optionees) allowing optionees to purchase the Companys common stock pursuant to shareholder approved stock option plans. As permitted by Statement of Financial Accounting Standards (SFAS) No. 148, Accounting for Stock-Based Compensation-Transitional Disclosure, the Company has elected to follow Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees and related interpretations in accounting for its employee stock options (APB 25). Under APB 25, in the event that the exercise price of the Companys employee stock options is less than the market price of the underlying stock on the date of grant, compensation expense is recognized. No stock-based employee compensation cost is reflected in net (loss) income, as all options granted under the Companys employee stock options plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net (loss) income and (loss) income per share if the Company had applied the fair value recognition provisions of SFAS No. 123 to stock-based employee compensation.
| Quarter | Quarter | Nine Months | Nine Months | |||||||||||||
| Ended | Ended | Ended | Ended | |||||||||||||
| 2/29/04 |
2/28/03 |
2/29/04 |
2/28/03 |
|||||||||||||
Net (loss) income, as reported |
$ | (78 | ) | $ | 7,706 | $ | (636 | ) | $ | 7,980 | ||||||
Deduct: |
||||||||||||||||
Total stock-based employee compensation expense determined
under fair value based method for all awards, net of related tax
effects |
(96 | ) | (117 | ) | (206 | ) | (179 | ) | ||||||||
Pro forma net (loss) income |
$ | (174 | ) | $ | 7,589 | $ | (842 | ) | $ | 7,801 | ||||||
(Loss) income per common share: |
||||||||||||||||
Basic as reported |
$ | (0.02 | ) | $ | 1.97 | $ | (0.15 | ) | $ | 2.05 | ||||||
Diluted as reported |
$ | (0.02 | ) | $ | 1.71 | $ | (0.15 | ) | $ | 1.87 | ||||||
Basic pro forma |
$ | (0.04 | ) | $ | 1.94 | $ | (0.20 | ) | $ | 2.00 | ||||||
Diluted pro forma |
$ | (0.04 | ) | $ | 1.68 | $ | (0.20 | ) | $ | 1.82 | ||||||
Per Share data
In calculating basic (loss) income per share, net (loss) income is divided by the weighted average number of common shares outstanding for the period. Diluted (loss) income per share reflects the assumed exercise or conversion of all dilutive securities, such as options, warrants, and convertible debentures. No such exercise or conversion is assumed where the effect is antidilutive, such as when there is a net loss. The following table sets forth the computation of basic and diluted (loss) income per share in accordance with SFAS No. 128, Earnings Per Share (amounts in thousands, except per share data):
7
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
| Three Months Ended | Nine months ended | |||||||||||||||
| February 29, | February 28, | February 29, | February 28, | |||||||||||||
| 2004 |
2003 |
2004 |
2003 |
|||||||||||||
Numerator: |
||||||||||||||||
(Loss) income per share from continuing
operations |
$ | (78 | ) | $ | 7,706 | $ | (249 | ) | $ | 7,980 | ||||||
Loss from discontinued operations |
| | (387 | ) | | |||||||||||
Net (loss) income attributable to common stockholders |
$ | (78 | ) | $ | 7,706 | $ | (636 | ) | $ | 7,980 | ||||||
Denominator: |
||||||||||||||||
Weighted average shares |
4,585 | 3,908 | 4,154 | 3,897 | ||||||||||||
Effect of dilutive securities: |
||||||||||||||||
Employee stock options |
| 600 | | 380 | ||||||||||||
Warrants |
| 1 | | | ||||||||||||
Denominator for diluted (loss) income per share-adjusted weighted
average shares after assumed conversions |
4,585 | 4,509 | 4,154 | 4,277 | ||||||||||||
Basic (loss) income per share: |
||||||||||||||||
(Loss) income from continuing operations |
$ | (0.02 | ) | $ | 1.97 | $ | (0.06 | ) | $ | 2.05 | ||||||
Loss from discontinued operations |
| | (0.09 | ) | | |||||||||||
Net (loss) income |
$ | (0.02 | ) | $ | 1.97 | $ | (0.15 | ) | $ | 2.05 | ||||||
Diluted (loss) income per share: |
||||||||||||||||
(Loss) income from continuing operations |
$ | (0.02 | ) | $ | 1.71 | $ | (0.06 | ) | $ | 1.87 | ||||||
Loss from discontinued operations |
| | (0.09 | ) | | |||||||||||
Net (loss) income |
$ | (0.02 | ) | $ | 1.71 | $ | (0.15 | ) | $ | 1.87 | ||||||
Authorized shares of common stock reserved for possible issuance for convertible debentures and stock options are as follows at February 29, 2004:
Convertible debentures |
9,044 | |||
Outstanding stock options |
1,240,390 | |||
Possible future issuance under stock option plans |
306,569 | |||
Total |
1,556,003 | |||
Note 2 Basis of Presentation
The accompanying consolidated financial statements are prepared on a going concern basis. During the nine months ended February 29, 2004, net cash used in continuing and discontinued operations amounted to $1,291,000 and $53,000, respectively. The Company had $949,000 of net cash provided from financing activities, primarily through the sale of an aggregate of 700,000 shares of common stock in a private transaction completed in December 2003. This transaction reduced the Companys working capital deficiency and stockholders deficit each by approximately $972,000. Uses of cash during the nine months ended February 29, 2004 include $140,000 for the Companys ongoing implementation of its new, customized management information system. The Companys capital needs during Fiscal 2004 will require additional installments toward the $230,000 that remains to be paid in connection with this system, which has expected total costs of approximately $370,000. Once implemented, this system will enable the Company to meet HIPAA requirements, streamline the Companys entire clinical and claims functions, and offer service improvements to the Companys participating providers. As of February 29, 2004, the Company had a working capital deficiency of $3.9 million and a stockholders deficit of $4.6 million. The Company is continuing to pursue sources of financing on terms that would support the Companys capital needs and provide available funds for working capital during Fiscal 2004. Management cannot state with any degree of certainty whether any required additional equity or debt financing will be available to the Company during Fiscal 2004 and, if available, that the source of financing would be available on terms and conditions acceptable to the Company. These conditions raise substantial doubt about the Companys ability to continue as a going concern, which is dependent upon its ability to continue to generate sufficient cash flow to meet its obligations on a timely basis, obtaining additional financing as may be required and, ultimately, sustaining an operating profit. The accompanying consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty.
8
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 3 Major Customers/Contracts
(1) Beginning January 1, 2003, the Company contracted with a new HMO client to provide behavioral healthcare services to contracted Medicaid members in Florida. This business accounted for 20.8%, or $4.4 million, of the Companys operating revenues during the nine months ended February 29, 2004. During the prior fiscal year, such Medicaid members were serviced by the Company through its contract with another HMO whose agreements with the Company covered Medicaid, Medicare, and commercial members and represented a combined 19.7%, or $4.9 million, of the Companys operating revenue for the nine months ended February 28, 2003. On December 31, 2002, the Company received a formal termination notice, effective February 28, 2003, from the prior HMO client with respect to the Medicare and commercial business. In addition, the acquiring HMO, whose contract with the Company was scheduled to renew in January 2004, formally advised the Company on October 30, 2003 that it had determined to insource behavioral health and, therefore, would not renew its contract with the Company. Accordingly, the Companys contract with this HMO customer terminated effective December 31, 2003. In response to the loss of revenue specific to this contract, the Company restructured its regional and corporate operations, centralized certain clinical and administrative functions, reduced staffing, and eliminated certain expenses that could not be supported with existing and remaining revenues.
(2) The Company has one contract to provide behavioral healthcare services to Connecticut members under contract with one HMO. This agreement represented approximately 12.7%, or $2.7 million, and 8.6%, or $2.2 million, of the Companys operating revenue for the nine months ended February 29, 2004 and February 28, 2003, respectively. Additionally, this contract provides that the Company, through its contract with this HMO, receives additional funds directly from a state reinsurance program for the purpose of paying providers. During the nine months ended February 29, 2004 and February 28, 2003, the Company filed reinsurance claims totaling approximately $1.5 million and $2.3 million, respectively. Such claims represent cost reimbursements and, as such, are not included in the reported operating revenues and are accounted for as reductions of healthcare operating expenses. As of February 29, 2004 and May 31, 2003, respectively, the Company has reported $3.0 million and $3.1 million as accrued reinsurance claims payable, with $0.4 million reported as accounts receivable-managed care reinsurance contracts as of each date. In the event that the Company does not collect the amounts receivable related to reinsurance amounts, the Company could remain liable for the costs of the specific services provided to members that qualify for such reimbursements. The difference between the reinsurance receivable amount and the reinsurance payable amount is related to timing differences between the authorization date, the date the money is received by the Company, and the date the money is paid to the provider. In certain cases, providers have submitted claims for authorized services having incorrect service codes or otherwise incorrect information that has caused payment to be denied by the Company. In such cases, there are contractual and statutory provisions that allow the provider to appeal a denied claim. If no appeal is received by the Company within the prescribed amount of time, the Company may be required to remit the reinsurance funds back to the appropriate party. For non-reinsurance claims incurred but not reported under this contract, the Company estimates its claims payable using a similar method as that used for other existing contracts. This HMO has been a customer since March 2001. The original contract term ended December 31, 2002 and, in accordance with its terms, has automatically renewed for two consecutive one-year periods, with the current term ending December 31, 2004.
(3) The Company has contracts with one HMO to provide behavioral healthcare services to contracted commercial, Medicaid, and Childrens Health Insurance Program (CHIP) members in Texas. This business accounted for approximately 13.0%, or $2.8 million, and 11.4%, or $2.9 million, of the Companys operating revenues during the nine months ended February 29, 2004 and February 28, 2003, respectively. Benefits available to Texas CHIP recipients were significantly reduced for the five month period September 1, 2003 to January 31, 2004 as a result of legislative bills passed by the Texas State legislature. Consequently, CHIP business under this contract accounted for approximately $0.9 million, or 4.2%, of operating revenues as compared to $1.7 million, or 7.0% of operating revenues for the nine month periods ended February 29, 2004 and February 28, 2003, respectively. Subsequent legislation has restored the majority of benefits available to CHIP recipients effective February 1, 2004. This HMO has been a customer of the Company since November 1998. The original contract term was for one year and the contract provides for automatic one-year renewal terms.
(4) During the prior fiscal year, the Company had three contracts with one HMO to provide behavioral healthcare services to Florida members. The combined revenue from these contracts accounted for 15.1%, or $3.8 million, of the Companys operating revenues during the nine months ended February 28, 2003. These contracts covering Florida members terminated effective January 1, 2003. Additionally, the Company has one major contract with an affiliate of this HMO (see Item 2 above).
9
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Although there can be no assurance that the Company will be able to reduce its costs in an amount sufficient to offset the loss of gross margins associated with the customer listed under (1) above, the Company has undertaken efforts to restructure its regional and corporate operations, including the centralization of certain clinical and administrative functions, generalized staff downsizing, and the elimination of certain expenses that cannot be supported with existing and remaining revenues, to minimize any effect on future results of operations.
In general, the Companys contracts with its customers are typically for initial one-year terms, with automatic annual extensions. Such contracts generally provide for cancellation by either party with 60 to 90 days written notice.
Note 4 Discontinued Operations
Results for the nine months ended February 29, 2004 include a change in estimate resulting in a $387,000 charge recorded in August 2003 and included under Discontinued Operations in the accompanying financial statements. Such charge primarily relates to settlement of the Companys Fiscal 1999 Medicare cost report for its Aurora, Colorado facility that was sold by the Company during Fiscal 1999. The Company has determined not to appeal the Medicare intermediarys determination and has accepted the settlement requiring the Company to repay $400,000 specific to Fiscal 1999, less approximately $106,000 in Medicare refunds that were due the Company in connection with its Fiscal 1995 and 1996 Medicare cost report settlements for this same Aurora, Colorado hospital. Further, the Medicare intermediary has accepted the Companys proposed, 24-month, 12.125% installment payment plan to repay the net amount of approximately $300,000, of which $241,000 remains to be paid as of February 29, 2004. Of the remaining amount, approximately $147,000 is included in accounts payable and accrued expenses and $94,000 in long-term liabilities in the accompanying balance sheet at February 29, 2004.
Note 5 Commitments and Contingencies
(1) A contract with one existing client requires the Company to maintain a performance bond throughout the contract term. At February 29, 2004, the Company maintained a $600,000 performance bond in compliance with this requirement.
(2) Related to the Companys discontinued hospital operations, Medicare guidelines allow the Medicare fiscal intermediary to re-open previously filed cost reports. Management believes that the Companys Fiscal 1998 and 1999 cost reports remain eligible for re-opening at some future date, in which case the intermediary may determine that additional amounts are due to or from Medicare.
(3) The Company is subject to the requirements of the Health Insurance Portability and Accountability Act of 1996 (HIPAA). The purpose of the HIPAA provisions is to improve the efficiency and effectiveness of the healthcare system through standardization of the electronic data interchange of certain administrative and financial transactions and, also, to protect the security and privacy of protected health information. Entities subject to HIPAA include some healthcare providers and all healthcare plans. To meet the specific requirements of HIPAA, the Company recently determined it needed to make a significant investment in its current information system or in a new information system that would better meet the Companys future needs. As a result, the Company has entered into a Software License Maintenance and Services Agreement with Qualifacts Systems, Inc. (Qualifacts), a vendor that has provided the Company with an immediate, temporary solution to meet HIPAA compliance rules specific to the Electronic Health Care Transactions and Code Sets Standards Model Compliance Plan with the Centers for Medicare and Medicaid Services and, additionally, to design a new, customized management information system that will enable the Company to continue to meet HIPAA requirements in the future. The Company expects to incur a total of approximately $0.4 million of costs to customize the Qualifacts system and activate the licenses needed for Qualifacts and other, related third-party software.
From time to time, the Company and its subsidiaries are also parties and their property is subject to ordinary, routine litigation incidental to their business, in which case claims may exceed insurance policy limits and the Company or any one of its subsidiaries may have exposure to a liability that is not covered by insurance. Management is not aw